Correlation
The correlation between SPRY and PG is 0.31, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
SPRY vs. PG
Compare and contrast key facts about Silverback Therapeutics Inc (SPRY) and The Procter & Gamble Company (PG).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: SPRY or PG.
Performance
SPRY vs. PG - Performance Comparison
Loading data...
Key characteristics
SPRY:
0.91
PG:
0.37
SPRY:
1.60
PG:
0.58
SPRY:
1.20
PG:
1.08
SPRY:
0.69
PG:
0.57
SPRY:
2.84
PG:
1.25
SPRY:
21.36%
PG:
5.37%
SPRY:
68.50%
PG:
19.16%
SPRY:
-95.20%
PG:
-54.23%
SPRY:
-76.11%
PG:
-4.27%
Fundamentals
SPRY:
$1.42B
PG:
$398.31B
SPRY:
-$0.16
PG:
$6.35
SPRY:
14.59
PG:
4.75
SPRY:
6.19
PG:
7.74
SPRY:
$97.12M
PG:
$83.93B
SPRY:
$95.01M
PG:
$43.05B
SPRY:
-$27.05M
PG:
$23.39B
Returns By Period
In the year-to-date period, SPRY achieves a 36.78% return, which is significantly higher than PG's 2.61% return.
SPRY
36.78%
1.91%
-0.55%
62.50%
60.50%
N/A
N/A
PG
2.61%
6.19%
-4.04%
5.79%
7.41%
10.64%
11.07%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
SPRY vs. PG — Risk-Adjusted Performance Rank
SPRY
PG
SPRY vs. PG - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Silverback Therapeutics Inc (SPRY) and The Procter & Gamble Company (PG). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Loading data...
Dividends
SPRY vs. PG - Dividend Comparison
SPRY has not paid dividends to shareholders, while PG's dividend yield for the trailing twelve months is around 2.40%.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
SPRY Silverback Therapeutics Inc | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
PG The Procter & Gamble Company | 2.40% | 2.36% | 2.55% | 2.38% | 2.08% | 2.24% | 2.37% | 3.09% | 2.98% | 3.18% | 3.32% | 2.78% |
Drawdowns
SPRY vs. PG - Drawdown Comparison
The maximum SPRY drawdown since its inception was -95.20%, which is greater than PG's maximum drawdown of -54.23%. Use the drawdown chart below to compare losses from any high point for SPRY and PG.
Loading data...
Volatility
SPRY vs. PG - Volatility Comparison
Silverback Therapeutics Inc (SPRY) has a higher volatility of 19.36% compared to The Procter & Gamble Company (PG) at 4.74%. This indicates that SPRY's price experiences larger fluctuations and is considered to be riskier than PG based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading data...
Financials
SPRY vs. PG - Financials Comparison
This section allows you to compare key financial metrics between Silverback Therapeutics Inc and The Procter & Gamble Company. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities